Both in Biotechnology
Protara Therapeutics vs Sutro Biopharma
Over the past year TARA returned −52.9% and STRO returned −13.5%; their daily moves had a correlation of 0.31.
TARA −52.9% STRO −13.5%Growth of $1, one year, split-adjusted
| Metric | TARA | STRO |
|---|---|---|
| Price | $2.41 | $9.51 |
| Market cap | $142.4M | $157.7M |
| Today | 0.00% | +4.39% |
| 1 month | −8.4% | −37.1% |
| 6 months | −55.5% | −74.5% |
| Year to date | −54.8% | −17.8% |
| 1 year | −53.5% | −15.1% |
| Revenue growth (YoY) | — | −84.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −391.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.5× |
| Net cash | $142.5M | $164.3M |
| Dividend yield | — | — |
| Volatility (60d) | 49.0% | 74.3% |
| Short % of float | 11.5% | 13.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).